National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 45222-45223 [2020-16181]
Download as PDF
<![CDATA[
45222
Federal Register / Vol. 85, No. 144 / Monday, July 27, 2020 / Notices
Dated: July 22, 2020.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2020–16243 Filed 7–24–20; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Application Requirements for
the Low Income Home Energy
Assistance Program (LIHEAP) Model
Plan Application (OMB #0970–0075)
Office of Community Services,
Administration for Children and
Families, HHS.
ACTION: Request for public comment.
AGENCY:
The Office of Community
Services (OCS), Administration for
Children and Families (ACF), U.S.
Department of Health and Human
SUMMARY:
Services (HHS), is requesting a 3-year
extension of the form OCS–0024: Low
Income Home Energy Assistance
Program (LIHEAP) Model Plan
Application (OMB #0970–0075,
expiration 9/30/2020). There are no
changes requested to the form.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
ACF is soliciting public comment on the
specific aspects of the information
collection described above.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by emailing infocollection@
acf.hhs.gov. Alternatively, copies can
also be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation (OPRE), 330 C Street
SW, Washington, DC 20201, Attn: ACF
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: States, including the
District of Columbia, tribes, tribal
organizations, and U.S. territories
applying for LIHEAP block grant funds
must, prior to receiving federal funds,
submit an annual application (Model
Plan, ACF–122) that meets the LIHEAP
statutory and regulatory requirements.
In addition to the Model Plan, grantees
are also required to complete the
Mandatory Grant Application, SF–424—
Mandatory, which is included as the
first section of the Model Plan.
The LIHEAP Model Plan is an
electronic form and is submitted to
OCS/ACF through the On-Line Data
Collection (OLDC) system within
GrantSolutions, which is currently
being used by all LIHEAP grantees to
submit other required LIHEAP reporting
forms. In order to reduce the reporting
burden, all data entries from each
grantee’s prior year’s submission of the
Model Plan in OLDC are saved and repopulated into the form for the
following fiscal year’s application.
Respondents: States, the District of
Columbia, U.S. territories, and tribal
governments.
ANNUAL BURDEN ESTIMATES
Total annual
number of
respondents
Instrument
LIHEAP Detailed Model Plan ..........................................................................
jbell on DSKJLSW7X2PROD with NOTICES
Estimated Total Annual Burden
Hours: 105.
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
(Authority: 42 U.S.C. 8621)
John M. Sweet Jr.,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–16197 Filed 7–24–20; 8:45 am]
BILLING CODE 4184–80–P
VerDate Sep<11>2014
19:31 Jul 24, 2020
Jkt 250001
210
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Emergency Awards: Rapid
Investigation of Severe Acute Respiratory
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Total annual
number of
responses per
respondent
1
Average
burden
hours per
response
.50
Total annual
burden hours
105
Syndrome Coronavirus 2 (SARS-CoV–2) and
Coronavirus Disease 2019 (COVID–19) (R21/
R01 Clinical Trial Not Allowed).
Date: August 13, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F52,
Rockville, MD 20892, (Telephone Conference
Call).
Contact Person: Margaret A. Morris Fears,
Ph.D., Scientific Review Officer, Scientific
Review Program, National Institute of Allergy
and Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F52,
Rockville, MD 20852, maggie.morrisfears@
nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
E:\FR\FM\27JYN1.SGM
27JYN1
Federal Register / Vol. 85, No. 144 / Monday, July 27, 2020 / Notices
Dated: July 21, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–16181 Filed 7–24–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Neurological Disorders and Stroke
Council, September 9, 2020, 12:30 p.m.
to September 10, 2020, 01:00 p.m.,
National Institutes of Health,
Neuroscience Center, Bethesda, MD
20892, which was published in the
Federal Register on October 18, 2019,
84FR55974.
The meeting notice is amended to
change the meeting format from in
person to video assisted meeting and to
change the meeting times each day. The
new meeting times are Wednesday,
September 9, 2020, from 1 p.m. to 5
p.m. (open session) and Thursday,
September 10, 2020, from 1 p.m. to 5
p.m. (closed session). The meeting is
partially Closed to the public.
Visit NINDS homepage for more
information: https://www.ninds.nih.gov/
News-Events/Events-Proceedings/
Events/National-Advisory-CouncilNANDSC-Meeting-September-2020.
Dated: July 21, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–16184 Filed 7–24–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
VerDate Sep<11>2014
19:31 Jul 24, 2020
Jkt 250001
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Clinical Trial
Implementation Cooperative Agreement
(U01), and Clinical Trial Planning Grant
(R34).
Date: August 25, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G33
Rockville, MD 20892, (Telephone Conference
Call).
Contact Person: David C Chang, Ph.D.
Scientific Review Officer Scientific Review
Program Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G33 Rockville, MD
20852, (301) 594–4218, changdac@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 21, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–16180 Filed 7–24–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke,
November 22, 2020, 06:00 p.m. to
November 24, 2020, 12:00 p.m.,
National Institutes of Health, Bethesda,
MD 20814, which was published in the
Federal Register on December 18, 2019,
84FR69383.
This notice is being amended to
announce that the meeting is cancelled.
The meeting is closed to the public.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Emergency Awards: Rapid
Investigation of Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV–2) and
Coronavirus Disease 2019 (COVID–19)
Date: August 21, 2020.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G22A
Rockville, MD 20892, (Telephone Conference
Call).
Contact Person: Inka I. Sastalla, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G22A Rockville, MD
20852, 301–761–6431, inka.sastalla@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 21, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–16183 Filed 7–24–20; 8:45 am]
BILLING CODE 4140–01–P
Dated: July 21, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–16182 Filed 7–24–20; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00065
Fmt 4703
Sfmt 9990
45223
E:\FR\FM\27JYN1.SGM
27JYN1
]]>Agencies
[Federal Register Volume 85, Number 144 (Monday, July 27, 2020)]
[Notices]
[Pages 45222-45223]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16181]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel Emergency Awards: Rapid
Investigation of Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21/R01
Clinical Trial Not Allowed).
Date: August 13, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F52,
Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Margaret A. Morris Fears, Ph.D., Scientific
Review Officer, Scientific Review Program, National Institute of
Allergy and Infectious Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F52, Rockville, MD 20852,
[email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
[[Page 45223]]
Dated: July 21, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-16181 Filed 7-24-20; 8:45 am]
BILLING CODE 4140-01-P
